Shire Pharmaceuticals Company Profile

Aggregated data from the web about Shire Pharmaceuticals

Company Name	Shire Pharmaceuticals
Website	https://en.wikipedia.org
Snippet	Shire plc was a UK-founded Jersey-registered specialty biopharmaceutical company.Originating in the United Kingdom with an operational base in the United States, its brands and products included Vyvanse, Lialda, and Adderall XR.Shire was acquired by Takeda Pharmaceutical Company on 8 January 2019.. Shire was a global biotechnology company focused on serving people with rare diseases and other ...
Fate	Acquired by Takeda
ISIN	JE00B2QKY057
Parent	Takeda Pharmaceutical Company (2019)
Defunct	2019
Founded	1986
Revenue	$15,160.6 million (2017)[1]
Website	www.shire.com
Industry	Pharmaceuticals
Traded as	NASDAQ: SHPG
Key people	Flemming Ornskov (CEO)Thomas Dittrich (CFO)
Net income	$4,271.5 million (2017)[1]
Former type	Subsidiary
Predecessor	Shire Pharmaceuticals Group Plc
Operating income	$2,455.2 million (2017)[1]
Number of employees	23,044 (2018)[2]

Shire Pharmaceuticals is part of the United Kingdom company list

Shire Pharmaceuticals is part of the Pharmaceuticals company list

Have a list of company names and need to update information? Use our Company Search tool.

Please note that Powrbot Inc does not own this content and cannot vouch for its accuracy, we simply aggregate public information for ease of research.

Want to update this profile? Please contact us here with a link to the public source verifying the edit.